| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 10/17/2001 | CN1073104C N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate |
| 10/17/2001 | CN1073101C Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 10/17/2001 | CN1073085C Process for prepn. O-desmethyl tramadol antimer |
| 10/17/2001 | CN1072954C Liquid medicine for giving up smoking and its preparing process |
| 10/17/2001 | CN1072945C Medicine for curing psychosis and prepn. process thereof |
| 10/17/2001 | CN1072937C Oral liquid for giving up drug |
| 10/17/2001 | CN1072930C Compsn. comrising tramadol material and non-steriodal anti-inflammatory drug |
| 10/16/2001 | US6303819 Sodium channel-blocking agent; chronic or neuropathic pain. |
| 10/16/2001 | US6303790 Process for the preparation of pyridine derivatives |
| 10/16/2001 | US6303789 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors |
| 10/16/2001 | US6303653 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 10/16/2001 | US6303650 Aminoindan derivatives |
| 10/16/2001 | US6303643 Therapy of migraine headache, hypertension, alcohol withdrawal, drug addiction, rheumatoid arthritis, presbyopia, ischemic pain, spasticity, diarrhea, nasal congestion, and urinary incontinence by administering benzothiazole derivative |
| 10/16/2001 | US6303637 For therapy of autoimmune disease, prophylaxis of resistance to transplantation or transplantation rejection of organs or tissues; suppressing immune system |
| 10/16/2001 | US6303633 Heteroaryl amines as novel acetylcholinesterase inhibitors |
| 10/16/2001 | US6303627 For therapy of physiological and psychological disorders |
| 10/16/2001 | US6303623 Bicycloloactam compounds, use thereof and intermediates for preparing thereof |
| 10/16/2001 | US6303615 2,3 disubstituded-4(3H)-quinazolinones |
| 10/16/2001 | US6303614 Tetrahydro gamma-carbolines |
| 10/16/2001 | US6303613 As nitric oxide synthase inhibitor useful in therapy or prophylaxis of inflammatory disease and pain |
| 10/16/2001 | US6303611 For therapy of hyperalgesis |
| 10/16/2001 | US6303608 2-{4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use |
| 10/16/2001 | US6303605 For therapy of anxiety and convulsions |
| 10/16/2001 | US6303603 3-oxo-2(H)-1,2,4-triazine derivatives as ligands of 5 HT1A receptors |
| 10/16/2001 | US6303602 Useful as analgesic, anesthetic, anti-inflammatory or neuroprotective agent, or for therapy of arthritis, stroke of functional bowel disease |
| 10/16/2001 | US6303601 Arylgycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 10/16/2001 | US6303600 Substituted azabicyclic compounds |
| 10/16/2001 | US6303597 For therapy of anxiety and convulsions |
| 10/16/2001 | US6303595 Use of mirtazapine for treating sleep apneas |
| 10/16/2001 | US6303591 For therapy of cushing's syndrome or depression |
| 10/16/2001 | US6303576 Contacting cell with modulating agent that comprises internalization moiety and compound having amino acid sequencel peptide analogue or peptidomimetic of compound which retains ablity to inhibit beta-catenin mediated response |
| 10/16/2001 | US6303333 Expression vector which codes polypeptides for the diagnosis and treatment of cancer, dietetics, inflammation, cardiovascular disorders, crohn's diseases, neuropathies and immune defects |
| 10/16/2001 | US6303314 T-cell receptor Vβ-Dβ-Jβ sequence and methods for its detection |
| 10/16/2001 | US6303127 Treatment of disease states |
| 10/16/2001 | US6302863 Method for removal of lipids via a perfluorocarbon tumescent solution |
| 10/16/2001 | CA2098302C Medicaments |
| 10/11/2001 | WO2001075454A2 Diagnosis and treatment of alzheimer's disease |
| 10/11/2001 | WO2001075440A2 Schizophrenia related genes |
| 10/11/2001 | WO2001075135A1 Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders |
| 10/11/2001 | WO2001075074A1 Novel proteins |
| 10/11/2001 | WO2001075064A2 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides |
| 10/11/2001 | WO2001074903A2 CD20/IgE-RECEPTOR LIKE MOLECULES AND USES THEREOF |
| 10/11/2001 | WO2001074902A2 Adenine binding g protein coupled receptors |
| 10/11/2001 | WO2001074896A1 Human polynucleotides, polypeptides, and antibodies |
| 10/11/2001 | WO2001074857A2 Methods and compositions for modulating integrin-mediated cell-cell interactions |
| 10/11/2001 | WO2001074856A2 Wnt-7b-like polypeptides and nucleic acids encoding same |
| 10/11/2001 | WO2001074837A1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 10/11/2001 | WO2001074835A1 O-glucosylated benzamide sglt2 inhibitors and method |
| 10/11/2001 | WO2001074834A1 O-aryl glucoside sglt2 inhibitors and method |
| 10/11/2001 | WO2001074820A1 Novel derivatives and analogues of galanthamin |
| 10/11/2001 | WO2001074815A2 Phenyl-substituted imidazopyridines |
| 10/11/2001 | WO2001074811A2 Substituted 1,3-thiazole compounds, their production and use |
| 10/11/2001 | WO2001074807A1 Indolylpyrrole derivatives and cell death inhibitors |
| 10/11/2001 | WO2001074806A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 10/11/2001 | WO2001074805A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
| 10/11/2001 | WO2001074804A1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatement of pain |
| 10/11/2001 | WO2001074797A1 Phenylsulphonylpiperazinyl derivatives as 5-ht receptor ligands |
| 10/11/2001 | WO2001074796A1 SUCCINOYLAMINO HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 10/11/2001 | WO2001074784A1 CYCLIC LACTAMS AS INHIBITORS OF A-β PROTEIN PRODUCTION |
| 10/11/2001 | WO2001074783A1 Cyclic lactams as inhibitors of a βετα protein production |
| 10/11/2001 | WO2001074779A1 Aminopyridines and their use as anticonvulsants and sodium channel blockers |
| 10/11/2001 | WO2001074775A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 10/11/2001 | WO2001074773A2 Phenyl-substituted indoles as histamine h3-receptor antagonists |
| 10/11/2001 | WO2001074769A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 10/11/2001 | WO2001074763A1 Aryl and heteroaryl sulfonates |
| 10/11/2001 | WO2001074756A1 Process for producing amine derivatives |
| 10/11/2001 | WO2001074506A1 Extrusion die |
| 10/11/2001 | WO2001074400A1 Transporters and drug delivery system by using the same |
| 10/11/2001 | WO2001074378A2 Promoting cell growth by inhibiting enabled proteins or their ligands |
| 10/11/2001 | WO2001074365A2 An efficacious dosage regimen of galantamine that reduces side effects |
| 10/11/2001 | WO2001074364A2 A use of galantamine for the treatment of alzheimer's disease; targeting the underlying cause of the disease |
| 10/11/2001 | WO2001074352A1 Compositions for promoting sleep |
| 10/11/2001 | WO2001074344A2 Small organic molecule regulators of cell proliferation |
| 10/11/2001 | WO2001074340A2 Drug combination for the treatment of headache comprising mirtazapine and paracetamol or a non-steroidal anti-inflammatory drug |
| 10/11/2001 | WO2001074339A2 A use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease |
| 10/11/2001 | WO2001074298A2 Methods and compositions for regulating memory consolidation |
| 10/11/2001 | WO2001074128A2 A novel polypeptide, microtubulin 11 and the polynucleotide encoding the polypeptide |
| 10/11/2001 | WO2001027119A3 Substance library containing bicyclic imidazo-5-yl-amines and/or bicyclic imidazo-3-yl-amines |
| 10/11/2001 | WO2001026621A3 Orally distintegrating composition comprising mirtazapine |
| 10/11/2001 | WO2001025269A3 Human g-protein coupled receptor |
| 10/11/2001 | WO2001025210A3 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands |
| 10/11/2001 | WO2001024816A3 Compositions and methods relating to the inhibition of casomorphin and gluteomorphin |
| 10/11/2001 | WO2001024763A3 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 10/11/2001 | WO2001022956A3 NOVEL COMBINATION OF LOTEPREDNOL AND β2-ADRENOCEPTOR AGONISTS |
| 10/11/2001 | WO2001022951A3 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis |
| 10/11/2001 | WO2001021202A3 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 10/11/2001 | WO2001019826A3 Triazolopyrimidine derivatives |
| 10/11/2001 | WO2001007470A3 Human nervous system-associated proteins |
| 10/11/2001 | WO2000064421A3 Use of n-acetylcysteine for the preparation of a medicament suitable for the intravenous administration to prevent oxidative stress in dialysed patients |
| 10/11/2001 | WO2000041472A3 Binding partners for 5-ht5-receptors for the treatment of migraine |
| 10/11/2001 | WO2000029549A3 Low oxygen culturing of cells |
| 10/11/2001 | US20010029264 In mixture with vitamin e, dimethylisosorbide, citric acid and polyoxyethylene glycol |
| 10/11/2001 | US20010029249 Adenovirus comprising a gene coding for glutathione peroxidase |
| 10/11/2001 | US20010029045 Lineage restricted glial precursors from the central nervous system |
| 10/11/2001 | US20010028895 Decreasing amyloid protein |
| 10/11/2001 | EP1144591A3 Low oxygen culturing of cells |
| 10/11/2001 | DE10015866A1 Aryl- und Heteroarylsulfonate Aryl and Heteroarylsulfonate |
| 10/11/2001 | CA2405319A1 Methods and compositions for modulating integrin-mediated cell-cell interactions |
| 10/11/2001 | CA2404965A1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 10/11/2001 | CA2404592A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |